Medicare AdvantageReimbursementMedium impact
MA01.006b, Reimbursement for Components of Comprehensive Laboratory Panels
Independence Blue Cross·Infectious Disease, OB-GYN, General Practice +2 more·Claims & Billing
Effective date
Feb 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated MA01.006b effective 02/01/2026 to change reimbursement methodology for Sexually Transmitted Infection (STI) component laboratory tests. When two or more STI component tests are reported on the same date by the same provider for the same member, reimbursement will be made for the individual comprehensive code (CPT 87801) instead of separate component codes. This policy continues to apply to all listed comprehensive laboratory panels across comprehensive metabolic panels, hepatic panels, and other organ-specific panels.
Action Required
By January 31, 2026: Billing team must update billing system and clearinghouse edits to bundle multiple STI component laboratory tests (reported on same date, same member, same provider/group) into CPT 87801. Review Attachment A for specific component codes that trigger bundling into comprehensive panels. Update claims submission logic to automatically combine eligible STI components into the comprehensive code to avoid claim denials. Train billing staff and providers on the new bundling requirement. Communicate to all ordering providers that individual STI component test billing will result in automatic rebundling and reimbursement at the comprehensive rate only. Verify documentation of medical necessity is available in member records before processing claims, as Company reserves right to audit.